170 related articles for article (PubMed ID: 370755)
1. [The apheresis: plasmapheresis, plateletpheresis, leukapheresis. Physiopathology of the donor (author's transl)].
Avanzi G
Pathologica; 1978; 70(1007-1008):467-80. PubMed ID: 370755
[No Abstract] [Full Text] [Related]
2. [Hemolysis following cytapheresis. 2 cases].
Schooneman F; Janot C; Streiff F
Nouv Presse Med; 1980 Feb; 9(8):540. PubMed ID: 7367294
[No Abstract] [Full Text] [Related]
3. Multiple pheresis - effect on the donor.
Ho W
Prog Clin Biol Res; 1981; 65():91-9. PubMed ID: 7330074
[No Abstract] [Full Text] [Related]
4. [Applications of blood separation (author's transl)].
Kennes B; Hubert C; Brohée D
Rev Med Brux; 1980 Apr; 1(4):277-9. PubMed ID: 7466026
[No Abstract] [Full Text] [Related]
5. Future trends in apheresis.
Freireich EJ
Prog Clin Biol Res; 1981; 65():155-62. PubMed ID: 7330070
[No Abstract] [Full Text] [Related]
6. [Adverse effects of hemapheresis].
Bláha M; Jebavý L; Siroký O; Malý J; Pecka M
Vnitr Lek; 1989 Oct; 35(10):972-81. PubMed ID: 2617884
[TBL] [Abstract][Full Text] [Related]
7. Blood component collection and transfusion.
Hester JP; McCredie KB; Freireich EJ; Kellogg RM; Mulzet A
Compr Ther; 1979 Feb; 5(2):59-62. PubMed ID: 428208
[No Abstract] [Full Text] [Related]
8. [The effects of leucapheresis and plateletpheresis using celltrifuge and Haemonetics Model 30 on normal donors (author's transl)].
Inoue K; Shimoyama M; Minato K; Takenaka T; Kitahara T; Sakano T; Konda C; Kimura K
Rinsho Ketsueki; 1979 Jan; 20(1):25-32. PubMed ID: 423372
[No Abstract] [Full Text] [Related]
9. [Side effects of thrombocytapheresis and leukocytapheresis in healthy donors].
Höcker P; Wagner A; Puffer G; Michl U
Beitr Infusionther Klin Ernahr; 1987; 18():205-9. PubMed ID: 3439974
[No Abstract] [Full Text] [Related]
10. [Blood donation (selection of donors, protection of donors and recipients, collection technics, possible complications, methods of blood donation].
Wegener S
Z Arztl Fortbild (Jena); 1982 Feb; 76(3):77-82. PubMed ID: 7043917
[No Abstract] [Full Text] [Related]
11. Health risk of leukapheresis donors.
Sandler SG; Nusbacher J
Haematologia (Budap); 1982; 15(1):57-69. PubMed ID: 6180961
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory effects on donors of intermittent-flow centrifugation platelet-leukapheresis performed with hydroxyethyl starch and citrate.
Strauss RG; Koepke JA; Maguire LC; Thompson JS
Clin Lab Haematol; 1980; 2(1):1-11. PubMed ID: 6155239
[No Abstract] [Full Text] [Related]
13. Current status of leukocyte and platelet administration in cancer therapy.
Walker EM; Cannon A; Mitchum EN
Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
[TBL] [Abstract][Full Text] [Related]
14. Practical considerations for planning a therapeutic apheresis procedure.
Shelat SG
Am J Med; 2010 Sep; 123(9):777-84. PubMed ID: 20541168
[TBL] [Abstract][Full Text] [Related]
15. Normal donor monitoring standards.
Menitove JE; Grindon AJ; Nusbacher J; Price TH; Aster RH
J Clin Apher; 1983; 1(3):124-9. PubMed ID: 6546051
[No Abstract] [Full Text] [Related]
16. [Problems in blood donors in plasmapheresis and cytopheresis].
Fiala J
Vnitr Lek; 1982 Feb; 28(2):182-8. PubMed ID: 7064373
[No Abstract] [Full Text] [Related]
17. Health risks to cytapheresis donors.
Westphal RG
Clin Haematol; 1984 Feb; 13(1):289-301. PubMed ID: 6202448
[TBL] [Abstract][Full Text] [Related]
18. Cytapheresis and plasmapheresis.
Mishler JM
Blood; 1984 Jul; 64(1):321-2. PubMed ID: 6733282
[No Abstract] [Full Text] [Related]
19. The International Apheresis Registry: results of 1983 second pilot.
Malchesky PS; Skibinski CI; Williams GW; Nosé Y
Artif Organs; 1987 Apr; 11(2):173-82. PubMed ID: 3593045
[TBL] [Abstract][Full Text] [Related]
20. Adverse effects in donors and patients subjected to hemapheresis.
Huestis DW
J Clin Apher; 1984; 2(1):81-90. PubMed ID: 6536662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
